Today: 16 April 2026
SoFi Stock Price Falls Again as Muddy Waters Fight Keeps Pressure on Shares
26 March 2026
1 min read

SoFi Stock Price Falls Again as Muddy Waters Fight Keeps Pressure on Shares

NEW YORK, March 26, 2026, 12:50 PM EDT

SoFi Technologies dropped roughly 3.7% to $15.94 by midday Thursday, with traders still digesting last week’s short-seller attack alongside a strong rebuttal from Mizuho.

This shift is notable, as SoFi entered March riding a wave of momentum. The company logged $1 billion in adjusted fourth-quarter revenue in January—excluding certain items—while loan originations hit a record $10.5 billion. Executives then projected first-quarter adjusted net revenue of about $1.04 billion.

Muddy Waters Research, the short seller known for betting against stocks, alleged on March 17 that SoFi could be carrying as much as $312 million in undisclosed debt from a JPMorgan loan deal. The firm also cast doubt on SoFi’s student loan discount rate and raised concerns over the lender’s reported charge-off numbers—the amount SoFi doesn’t expect to recover.

SoFi fired back that same day, blasting the report as “factually inaccurate and misleading” and adding that it’s considering legal options. According to the company, Muddy Waters displayed a “fundamental lack of understanding” of SoFi’s business and financials. SoFi Investors

Mizuho’s Dan Dolev acknowledged this week that the short report packed in “an impressive amount of detail and analysis,” but said its claims “could likely be refuted using SoFi’s public disclosures.” The firm stuck with its Outperform rating and a $38 target, backing SoFi’s account that the contested JPMorgan deal was a sale of senior secured loans—not covert borrowing. Investing.com

Anthony Noto, the chief executive, made a move of his own, snapping up 28,900 shares on March 17 at a weighted average price of $17.3189, according to a Form 4. His directly held stake climbs to over 11.7 million shares.

Thursday’s decline outpaced several peers. Upstart slipped roughly 2.5%, LendingClub gave up 1.8%, and Affirm barely budged. The Invesco QQQ Trust, tracking the Nasdaq-100, dropped around 1.5%.

The bigger danger here: this dispute might just drag on. If these allegations lead to wider scrutiny or push SoFi into devoting extra effort to fending off questions about its accounting, volatility could stick with the stock—even if underlying growth holds up. That’s just what the standoff implies so far, not a sure thing.

SoFi shares are still sliding, changing hands at $15.94—about 8% under the price CEO Noto just paid. Despite the latest insider buy and a favorable analyst call, neither has managed to erase the gap since Muddy Waters’ move.

Stock Market Today

  • NOV Stock Valuation: Contrasting Short-Term Price Moves and Long-Term Momentum
    April 16, 2026, 1:11 AM EDT. NOV (ticker: NOV) has gained 4.6% over one month and 5.5% in three months, yet its 12-month total return stands at a robust 64%. Shares currently trade at $19.02, slightly below a fair value estimate of $20.10, suggesting a modest valuation gap rooted in expectations of future cash flow and execution. Contrastingly, a discounted cash flow (DCF) model values NOV at $29.08, implying a 34.6% undervaluation. The stock's outlook depends on sustained global energy infrastructure investments, especially in LNG and gas processing. However, risks from tariffs, inflation, and pricing pressure could impact margins. Investors are advised to assess these conflicting signals and consider broader opportunities in energy infrastructure sectors as momentum builds steadily over the long term.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.04.2026

16 April 2026
LIVEMarkets rolling coverageStarted: April 16, 2026, 12:00 AM EDTUpdated: April 16, 2026, 1:13 AM EDT NOV Stock Valuation: Contrasting Short-Term Price Moves and Long-Term Momentum April 16, 2026, 1:11 AM EDT. NOV (ticker: NOV) has gained 4.6% over one month and 5.5% in three months, yet its 12-month total return stands at a robust 64%. Shares currently trade at $19.02, slightly below a fair value estimate of $20.10, suggesting a modest valuation gap rooted in expectations of future cash flow and execution. Contrastingly, a discounted cash flow (DCF) model values NOV at $29.08, implying a 34.6% undervaluation. The stock's outlook
Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Meta Layoffs Test $3 Trillion Hopes as AI Spending Surges
Previous Story

Meta Layoffs Test $3 Trillion Hopes as AI Spending Surges

AMD Stock Price Today: Shares Slide After a 7% Surge as Chip Rally Reverses
Next Story

AMD Stock Price Today: Shares Slide After a 7% Surge as Chip Rally Reverses

Go toTop